SYAB

DE000A2TSL71

Healthcare Facilities & Services

Market Closed - Xetra Other stock markets 09:05:14 10/05/2024 pm IST			After market 11:17:21 pm
10.24 ^EUR	-0.78%		10.31	+0.68%

08/05	Transcript : SYNLAB AG, Q1 2024 Earnings Call, May 08, 2024
08/05	Laboratory chain Synlab starts the year with lower revenue	DP

SYNLAB : From Neutral to Buy by Deutsche Bank

July 31, 2023 at 01:14 pm IST

Deutsche Bank's analyst Jan Koch raises his rating from Neutral to Buy. The target price is increased from EUR 9 to EUR 12.

Latest news about SYNLAB AG

Transcript : SYNLAB AG, Q1 2024 Earnings Call, May 08, 2024	08/05
Laboratory chain Synlab starts the year with lower revenue	08/05	DP
SYNLAB AG Provides Earnings Guidance for the Year 2024	08/05	CI
Certain Ordinary Bearer Shares of SYNLAB AG are subject to a Lock-Up Agreement Ending on 1-MAY-2024.	01/05	CI
Synlab’s Italian Unit Gradually Resumes Operations After Cyberattack	30/04	MT
Synlab Faces Cyber Attack in Italy	22/04	MT
Dpa-AFX Overview: COMPANIES - The most important news from the weekend	22/04	DP
SYNLAB AG(XTRA:SYAB) dropped from S&P Global BMI Index	15/04	CI
Tranche Update on SYNLAB AG's Equity Buyback Plan announced on September 22, 2022.	05/04	CI
Dpa-AFX Overview: COMPANIES from 25.03.2024 - 15:15	25/03	DP
Transcript : SYNLAB AG, 2023 Earnings Call, Mar 25, 2024	25/03
Laboratory chain Synlab earns significantly less in 2023 - cancels dividend	25/03	DP
SYNLAB AG Reports Earnings Results for the Full Year Ended December 31, 2023	25/03	CI
Fitch Keeps Synlab on Rating Watch Negative Amid Cinven Takeover	22/03	MT
SYNLAB : JP Morgan sticks Neutral	05/12	ZD
Moody's Withdraws Synlab Rating	05/12	MT
Financial investor Singer also gets involved in Synlab takeover	23/11	DP
Dpa-AFX Overview: COMPANIES from 08.11.2023 - 15:15	08/11	DP
Transcript : SYNLAB AG, Q3 2023 Earnings Call, Nov 08, 2023	08/11
SYNLAB : Jefferies reiterates its Neutral rating	08/11	ZD
Rising costs cause earnings at laboratory service provider Synlab to shrink	08/11	DP
SYNLAB AG Provides Earnings Guidance for the Year 2023	08/11	CI
SYNLAB AG Reports Earnings Results for the Nine Months Ended September 30, 2023	08/11	CI
FTSE 100 Closes Friday Lower, Weighed Down by Falling Oil Prices	03/11	DJ
Desert Frankfurt: Of canceled borse walks and farewells	12/23/12	DP

Synlab AG is a Germany based clinical laboratory and medical diagnostic services provider. The Company is engaged in laboratory services for human and veterinary medicine, as well as environmental analysis.

Sector

Healthcare Facilities & Services

Calendar

17/05/2024 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for SYNLAB AG

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

10.32 EUR

Average target price

14.5 EUR

Spread / Average Target

+40.50%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
SYNLAB AG	-10.33%	2.44B
SONIC HEALTHCARE LIMITED	-16.58%	8.44B
RADNET, INC.	+58.30%	3.96B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-39.78%	2.52B
DR. LAL PATHLABS LIMITED	-8.91%	2.22B
NEOGENOMICS, INC.	-3.96%	1.98B
FLEURY S.A.	-19.73%	1.58B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-38.30%	1.3B
METROPOLIS HEALTHCARE LIMITED	+2.19%	1.05B
NOVOGENE CO., LTD.	-34.96%	902M

Medical & Diagnostic Laboratories

SYNLAB AG

Equities

SYAB

DE000A2TSL71

Healthcare Facilities & Services

SYNLAB : From Neutral to Buy by Deutsche Bank

Latest news about SYNLAB AG

Chart SYNLAB AG

Company Profile

Income Statement Evolution

Ratings for SYNLAB AG

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Medical & Diagnostic Laboratories